Paige has been developing algorithms that can detect indiscernible-to-the-eye differences in hematoxylin and eosin-stained (H&E) biopsy slides, aiding doctors in the diagnosis of cancer.
The company has had a frantic past four years
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?